Monthly Archives: April 2011

N.C. pharma Pozen files court challenge to block generic competitor Looming patent expiration on the migraine drug Treximet has led pharmaceutical company Pozen to take further legal action to fend off generic competition. Chapel Hill, North Carolina-based Pozen (NASDAQ:POZN) said … Continue reading →

Research and Markets: China Pharmaceutical Chain Industry Report, 2010 Recent years have seen rapid growth of China’s pharmaceutical retail market, with expanding scale of chain enterprises and increasing number of drugstores, thanks to a fast-growing pharmaceutical industry and an aging … Continue reading →

Thousands of life sciences jobs lost in N.J. The pharmaceutical and medical device industries in New Jersey lost 4,900 jobs last year as business pressures led to a dramatic wave of consolidation that cost the state two venerable drug makers, … Continue reading →

Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as COO CHICAGO, Dec. 17, 2010 /PRNewswire/ — Millennium Pharmacy Systems, Inc. has announced that Philip J. Keough, IV has joined the company as Executive Vice President and Chief Operating Officer based in … Continue reading →

Gene E. Burleson, Healthcare Industry Executive and Director of Several NYSE-Listed Companies, Joins Vyteris Board of Directors FAIR LAWN, N.J.–(BUSINESS WIRE)–Vyteris, Inc. (OTCBB: VYTR), an innovator in alternative drug delivery technology, announces that Gene E. Burleson (age 69) has been … Continue reading →

Happy holidays? Not necessarily in the pharmaceutical sector Pharmaceutical manufacturers looking to cut costs need to keep focus on manufacturing/packaging to prevent product quality problems. ‘Tis the season to be jolly, right? Not necessarily in the pharmaceutical industry. A recent … Continue reading →